Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Mupirocin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mupirocin SCHEMBL18995884 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL14022405 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL1027616 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL2223711 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL15307512 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL15387504 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL18998277 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL15387505 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL19183296 | 1.00 | IARS1 (1.00) | IARS1HTR2A | |
| Mupirocin SCHEMBL14616863 | 1.00 | IARS1 (1.00) | IARS1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 27695 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120771790-B | Heating and melting tank for producing mupirocin ointment | HUBEI CHENGTIAN PHARMACEUTICAL CO.,LTD. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12636198-B2 | Bandage for providing protection and antimicrobial properties to a surgical site with one or more percutaneous pins or wires | ORTHOBARRIER TECHNOLOGIES LLC (US) | 2026-05-26 | — | — | US | claimed |
| CN-115215923-B | Macrocyclic broad-spectrum antibiotics | 豪夫迈·罗氏有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122005519-A | Flushing fluid for sodium dipping treatment of emergency environment of sodium-related factory building and preparation method thereof | 中国辐射防护研究院 | 2026-05-12 | — | — | CN | claimed |
| US-12616655-B2 | Topical antibiotic containing pharmaceutical composition for bacterial infections and wound healing | VISHAGAN VANANGAMUDI SULUR (IN) | 2026-05-05 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4729525-A1 | NEWLY SYNTHESIZED BORON-NITROGEN HETEROCYCLES AND THEIR CONJUGATES WITH PHARMACEUTICALLY UTILIZABLE SUBSTANCES | Julius-Maximilians-Universität Würzburg (DE) | 2026-04-22 | — | — | EP | claimed |
| US-12605484-B2 | Two-component system for the therapeutic treatment of skin lesions and production method thereof | DTECH - SOCIETÀ A RESPONSABILITÀ LIMITATA (IT) | 2026-04-21 | — | — | US | claimed |
| US-20260103492-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2026-04-16 | — | — | US | claimed |
| US-12594260-B2 | Topical formulations for infections | Topical Rx, LLC (US) | 2026-04-07 | — | — | US | claimed |
| EP-0093808-A1 | A method for improving the weight gain and feed utilisation efficiency of pigs | BEECHAM GROUP PLC (GB) | 1983-11-16 | — | — | EP | claimed |
| EP-0068680-A1 | Antibiotics | BEECHAM GROUP PLC (GB) | 1983-01-05 | — | — | EP | claimed |
| EP-0005614-B1 | LITHIUM PSEUDOMONATE, PROCESS FOR ITS ISOLATION AND ITS HYDROLYSIS | BEECHAM GROUP PLC (GB) | 1982-02-24 | — | — | EP | claimed |
| EP-0003069-B1 | PSEUDOMONIC ACID C, PHARMACEUTICALLY ACCEPTABLE SALTS OR ESTERS THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL OR VETERINARY COMPOSITIONS CONTAINING THEM | BEECHAM GROUP PLC (GB) | 1981-05-20 | — | — | EP | claimed |
| US-4222942-A | Isolation of organic acids | BEECHAM GROUP LIMITED (GB) | 1980-09-16 | — | — | US | claimed |
| US-4206224-A | PSEUDOMONIC ACID, SALT, OR ESTER, RESPIRATORY OR VENEREAL INFECTIONS | BEECHAM GROUP LIMITED (GB) | 1980-06-03 | — | — | US | claimed |
| US-4196214-A | BACTERICIDES, ANTIINFLAMMATORY AGENTS | BEECHAM GROUP LIMITED (GB) | 1980-04-01 | — | — | US | claimed |
| US-4186206-A | PSEUDOMONIC ACID, SALTS OR ESTERS | BEECHAM GROUP LIMITED (GB) | 1980-01-29 | — | — | US | claimed |
| EP-0005614-A1 | Lithium pseudomonate, process for its isolation and its hydrolysis | BEECHAM GROUP PLC (GB) | 1979-11-28 | — | — | EP | claimed |
| EP-0003069-A1 | Pseudomonic acid C, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them | BEECHAM GROUP PLC (GB) | 1979-07-25 | — | — | EP | claimed |